Clinician’s perspective regarding medication adherence in patients with obstructive lung diseases and the impact of COVID-19
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Revista da Associação Médica Brasileira (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302021000200097 |
Resumo: | SUMMARY OBJECTIVE: Failure to achieve high levels of medication adherence in obstructive lung diseases is a major cause of uncontrolled disease. The purpose of this study is to reveal clinicians’ opinions on the level of patient adherence and the change in adherence during the COVID-19 pandemic. METHODS: A questionnaire containing multiple-choice questions about treatment adherence in patients with obstructive lung diseases was voluntarily applied to doctors working in a tertiary hospital for chest diseases. RESULTS: Eighty-one doctors (mean age, 37.2 years [standard deviation, 9.7 years]; 57 (70.4%) women) answered the questionnaires. Almost all clinicians participating in the study reported that they always or frequently asked patients if they adhered to treatment. Most clinicians think that in 20–50% of patients with asthma and less than 20% of patients with chronic obstructive pulmonary disease, a decrease in medication adherence appears in the first year of treatment. Most clinicians think the main reason for patients with obstructive lung diseases not adhering is patients’ reluctance to be treated regularly. Regarding the impact of the COVID-19 pandemic on patients’ drug adherence, 43.2% of clinicians observed that adherence increased after the start of the pandemic. CONCLUSIONS: Adherence to medication is not at the desired levels in patients with obstructive lung diseases. However, when faced with a serious health threat, such as the COVID-19 pandemic, patients realize the severity of their illness and begin using their treatments more regularly. |
id |
AMB-1_7e3d971d1fd9b2dacc78308f729f5c56 |
---|---|
oai_identifier_str |
oai:scielo:S0104-42302021000200097 |
network_acronym_str |
AMB-1 |
network_name_str |
Revista da Associação Médica Brasileira (Online) |
repository_id_str |
|
spelling |
Clinician’s perspective regarding medication adherence in patients with obstructive lung diseases and the impact of COVID-19AsthmaPulmonary diseasechronic obstructiveCoronavirus infectionsMedication adherenceSUMMARY OBJECTIVE: Failure to achieve high levels of medication adherence in obstructive lung diseases is a major cause of uncontrolled disease. The purpose of this study is to reveal clinicians’ opinions on the level of patient adherence and the change in adherence during the COVID-19 pandemic. METHODS: A questionnaire containing multiple-choice questions about treatment adherence in patients with obstructive lung diseases was voluntarily applied to doctors working in a tertiary hospital for chest diseases. RESULTS: Eighty-one doctors (mean age, 37.2 years [standard deviation, 9.7 years]; 57 (70.4%) women) answered the questionnaires. Almost all clinicians participating in the study reported that they always or frequently asked patients if they adhered to treatment. Most clinicians think that in 20–50% of patients with asthma and less than 20% of patients with chronic obstructive pulmonary disease, a decrease in medication adherence appears in the first year of treatment. Most clinicians think the main reason for patients with obstructive lung diseases not adhering is patients’ reluctance to be treated regularly. Regarding the impact of the COVID-19 pandemic on patients’ drug adherence, 43.2% of clinicians observed that adherence increased after the start of the pandemic. CONCLUSIONS: Adherence to medication is not at the desired levels in patients with obstructive lung diseases. However, when faced with a serious health threat, such as the COVID-19 pandemic, patients realize the severity of their illness and begin using their treatments more regularly.Associação Médica Brasileira2021-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302021000200097Revista da Associação Médica Brasileira v.67 suppl.1 2021reponame:Revista da Associação Médica Brasileira (Online)instname:Associação Médica Brasileira (AMB)instacron:AMB10.1590/1806-9282.67.suppl1.20201095info:eu-repo/semantics/openAccessYıldız,MuratAksu,FundaYıldız,NurdanAksu,Kurtuluşeng2021-08-19T00:00:00Zoai:scielo:S0104-42302021000200097Revistahttps://ramb.amb.org.br/ultimas-edicoes/#https://old.scielo.br/oai/scielo-oai.php||ramb@amb.org.br1806-92820104-4230opendoar:2021-08-19T00:00Revista da Associação Médica Brasileira (Online) - Associação Médica Brasileira (AMB)false |
dc.title.none.fl_str_mv |
Clinician’s perspective regarding medication adherence in patients with obstructive lung diseases and the impact of COVID-19 |
title |
Clinician’s perspective regarding medication adherence in patients with obstructive lung diseases and the impact of COVID-19 |
spellingShingle |
Clinician’s perspective regarding medication adherence in patients with obstructive lung diseases and the impact of COVID-19 Yıldız,Murat Asthma Pulmonary disease chronic obstructive Coronavirus infections Medication adherence |
title_short |
Clinician’s perspective regarding medication adherence in patients with obstructive lung diseases and the impact of COVID-19 |
title_full |
Clinician’s perspective regarding medication adherence in patients with obstructive lung diseases and the impact of COVID-19 |
title_fullStr |
Clinician’s perspective regarding medication adherence in patients with obstructive lung diseases and the impact of COVID-19 |
title_full_unstemmed |
Clinician’s perspective regarding medication adherence in patients with obstructive lung diseases and the impact of COVID-19 |
title_sort |
Clinician’s perspective regarding medication adherence in patients with obstructive lung diseases and the impact of COVID-19 |
author |
Yıldız,Murat |
author_facet |
Yıldız,Murat Aksu,Funda Yıldız,Nurdan Aksu,Kurtuluş |
author_role |
author |
author2 |
Aksu,Funda Yıldız,Nurdan Aksu,Kurtuluş |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Yıldız,Murat Aksu,Funda Yıldız,Nurdan Aksu,Kurtuluş |
dc.subject.por.fl_str_mv |
Asthma Pulmonary disease chronic obstructive Coronavirus infections Medication adherence |
topic |
Asthma Pulmonary disease chronic obstructive Coronavirus infections Medication adherence |
description |
SUMMARY OBJECTIVE: Failure to achieve high levels of medication adherence in obstructive lung diseases is a major cause of uncontrolled disease. The purpose of this study is to reveal clinicians’ opinions on the level of patient adherence and the change in adherence during the COVID-19 pandemic. METHODS: A questionnaire containing multiple-choice questions about treatment adherence in patients with obstructive lung diseases was voluntarily applied to doctors working in a tertiary hospital for chest diseases. RESULTS: Eighty-one doctors (mean age, 37.2 years [standard deviation, 9.7 years]; 57 (70.4%) women) answered the questionnaires. Almost all clinicians participating in the study reported that they always or frequently asked patients if they adhered to treatment. Most clinicians think that in 20–50% of patients with asthma and less than 20% of patients with chronic obstructive pulmonary disease, a decrease in medication adherence appears in the first year of treatment. Most clinicians think the main reason for patients with obstructive lung diseases not adhering is patients’ reluctance to be treated regularly. Regarding the impact of the COVID-19 pandemic on patients’ drug adherence, 43.2% of clinicians observed that adherence increased after the start of the pandemic. CONCLUSIONS: Adherence to medication is not at the desired levels in patients with obstructive lung diseases. However, when faced with a serious health threat, such as the COVID-19 pandemic, patients realize the severity of their illness and begin using their treatments more regularly. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-01-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302021000200097 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302021000200097 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/1806-9282.67.suppl1.20201095 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Associação Médica Brasileira |
publisher.none.fl_str_mv |
Associação Médica Brasileira |
dc.source.none.fl_str_mv |
Revista da Associação Médica Brasileira v.67 suppl.1 2021 reponame:Revista da Associação Médica Brasileira (Online) instname:Associação Médica Brasileira (AMB) instacron:AMB |
instname_str |
Associação Médica Brasileira (AMB) |
instacron_str |
AMB |
institution |
AMB |
reponame_str |
Revista da Associação Médica Brasileira (Online) |
collection |
Revista da Associação Médica Brasileira (Online) |
repository.name.fl_str_mv |
Revista da Associação Médica Brasileira (Online) - Associação Médica Brasileira (AMB) |
repository.mail.fl_str_mv |
||ramb@amb.org.br |
_version_ |
1754212835998564352 |